Medicare Enrolled
Dr. Theodore Plush, D.O.
Internal Medicine · Camden, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Plush from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Plush?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Plush
Dr. Theodore Plush is an internal medicine specialist in Camden, NJ, with 15 years of NPI registration. Based on federal Medicare data, Dr. Plush performed 13,794 Medicare services across 1,415 unique beneficiaries.
Between the years covered by Open Payments, Dr. Plush received a total of $12,491 from 38 pharmaceutical and/or device companies across 358 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Plush is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 1% volume in NJ
$12,491 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,794
Medicare services
Top 1% in NJ for internal medicine
1,415
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~920 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, mepolizumab, 1 mg | 11,600 | $23 | $59 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
585 | $101 | $281 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
387 | $101 | $218 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
212 | $147 | $421 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
189 | $66 | $151 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
134 | $12 | $49 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $134 | $365 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
74 | $181 | $607 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
54 | $56 | $330 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
42 | $66 | $199 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
37 | $48 | $135 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
37 | $151 | $395 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
36 | $114 | $314 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
36 | $23 | $75 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
31 | $91 | $1,254 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
28 | $38 | $100 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
24 | $60 | $496 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
19 | $80 | $206 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
19 | $56 | $143 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
18 | $139 | $398 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $79 | $199 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $111 | $396 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
18 | $104 | $281 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
17 | $282 | $529 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
17 | $33 | $57 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $33 | $67 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
14 | $178 | $473 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes. |
12 | $205 | $985 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
12 | $72 | $146 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
12 | $9 | $129 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,491
Total received (2018-2024)
Avg $1,784/year across 7 years
Top 6% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
358
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,120 (57.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,205 (41.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$165 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,077
2023
$1,020
2022
$2,082
2021
$264
2020
$5,408
2019
$1,261
2018
$1,378
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$406
AstraZeneca Pharmaceuticals LP
$260
Regeneron Healthcare Solutions, Inc.
$70
Genentech USA, Inc.
$50
Amgen Inc.
$43
GENZYME CORPORATION
$39
Actelion Pharmaceuticals US, Inc.
$33
Mylan Specialty L.P.
$31
ABIOMED
$26
Inspire Medical Systems, Inc.
$21
United Therapeutics Corporation
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
JAZZ PHARMACEUTICALS INC.
$17
Philips North America LLC
$16
Optinose US, Inc.
$15
Insmed, Inc.
$15
Top 3 companies account for 68.4% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,578
Ethicon Inc.
$1,558
GlaxoSmithKline, LLC.
$1,222
Olympus Corporation of the Americas
$743
AstraZeneca Pharmaceuticals LP
$689
Regeneron Healthcare Solutions, Inc.
$501
Genentech USA, Inc.
$342
GENZYME CORPORATION
$264
Mylan Specialty L.P.
$135
Amgen Inc.
$135
Novartis Pharmaceuticals Corporation
$120
Insmed, Inc.
$108
Philips Electronics North America Corporation
$108
United Therapeutics Corporation
$96
Electromed, Inc.
$90
Teva Pharmaceuticals USA, Inc.
$80
Sunovion Pharmaceuticals Inc.
$79
Actelion Pharmaceuticals US, Inc.
$75
Shire North American Group Inc
$56
Grifols USA, LLC
$52
Takeda Pharmaceuticals U.S.A., Inc.
$45
JAZZ PHARMACEUTICALS INC.
$44
ABBVIE INC.
$37
Resmed Corp
$34
Optinose US, Inc.
$31
Jazz Pharmaceuticals Inc.
$30
Circassia Pharmaceuticals Inc
$27
Medtronic, Inc.
$26
ABIOMED
$26
PFIZER INC.
$25
Inspire Medical Systems, Inc.
$21
Boston Scientific Corporation
$20
Baxter Healthcare
$19
Philips North America LLC
$16
Harmony Biosciences LLC
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Nabriva Therapeutics, plc
$15
Janssen Pharmaceuticals, Inc
$14
Top 3 companies account for 66.9% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · Adempas · Arikayce · Astral · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CINQAIR · DALVANCE · DUPIXENT · Dymista · ELIQUIS · EXALT Model D · Esbriet · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · INSPIRE · Impella · LONHALA MAGNAIR · Monarch Platform · NIOX VERO · NUCALA · OER-PRO · OFEV · OPSUMIT · Olympus Respiratory Accessories · Perforomist · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · UPTRAVI · WAKIX · Wellcentive Undiv · XARELTO · XOLAIR · XYWAV · Xenleta · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · inCourage · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (57%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
4,166
Per 100K population
795.0
County median income
$86,384
Nearest hospital
COOPER UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Plush is a mixed practice specialist, with above-average Medicare volume (top 1% in NJ), with low-engagement industry engagement in the top 6% of NJ peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Plush experienced with injection, mepolizumab, 1 mg?
Based on Medicare claims data, Dr. Plush performed 11,600 injection, mepolizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Plush receive payments from pharmaceutical companies?
Yes. Dr. Plush received a total of $12,491 from 38 companies across 358 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Plush's costs compare to other internal medicine physicians in Camden?
Dr. Plush's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Plush) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Camden
Browse internal medicine physicians in Camden ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Ethicon Inc. Payments to Doctors
See all physicians who received payments from Ethicon Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology